A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors

Objective: The objective of this study was to test the superiority of multidisciplinary approach, that is, Short-Term Psychodynamic Psychotherapy (STPP) plus drug of choice, versus monotherapy, that is, OnabotulinumtoxinA (OnaBoNT-A). Method: We consecutively recorded data from chronic migraine (CM)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European neurology 2022-01, Vol.85 (6), p.453-459
Hauptverfasser:	Alessiani, Michele, Petolicchio, Barbara, De Sanctis, Rita, Squitieri, Martina, Di Giambattista, Romina, Puma, Marta, Franzese, Ciro, Toscano, Massimiliano, Derchi, Chiara-Camilla, Gilliéron, Edmond, Viganò, Alessandro, Di Piero, Vittorio
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics - therapeutic use Botulinum Toxins, Type A - therapeutic use Clinical Neurology: Research Article Headache Headache Disorders, Secondary - drug therapy Humans Migraine Disorders - drug therapy Propensity Score Psychotherapy, Psychodynamic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!